These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 35602577)

  • 21. Pango lineage designation and assignment using SARS-CoV-2 spike gene nucleotide sequences.
    O'Toole Á; Pybus OG; Abram ME; Kelly EJ; Rambaut A
    BMC Genomics; 2022 Feb; 23(1):121. PubMed ID: 35148677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan.
    Ko K; Takahashi K; Nagashima S; E B; Ouoba S; Hussain MRA; Akita T; Sugiyama A; Sakaguchi T; Tahara H; Ohge H; Ohdan H; Kubo T; Ishikawa N; Takafuta T; Fujii Y; Mimori M; Okada F; Kishita E; Ariyoshi K; Kuwabara M; Tanaka J
    Sci Rep; 2022 Feb; 12(1):2419. PubMed ID: 35165301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern.
    Yan T; Xu Y; Zheng R; Zeng X; Chen Z; Lin S; Xia Z; Liao Y; Zhang Y; Li Q
    Microbiol Spectr; 2022 Oct; 10(5):e0322222. PubMed ID: 36106882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early detection of emerging SARS-CoV-2 variants of interest for experimental evaluation.
    Wallace ZS; Davis J; Niewiadomska AM; Olson RD; Shukla M; Stevens R; Zhang Y; Zmasek CM; Scheuermann RH
    Front Bioinform; 2022; 2():1020189. PubMed ID: 36353215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.
    Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA
    J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Strategy for the Detection of SARS-CoV-2 Variants Based on Multiplex PCR-Mass Spectrometry Minisequencing Technology.
    Zhao F; Lu J; Lu B; Qin T; Wang X; Hou X; Meng F; Xu X; Li T; Zhou H; Zhang J; Kan B; Huang Y; Zhang Z; Xiao D
    Microbiol Spectr; 2021 Dec; 9(3):e0126721. PubMed ID: 34787499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants.
    Li J; Liu Q; Liu J; Fang Z; Luo L; Li S; Lei Y; Li Z; Jin J; Xie R; Peng Y
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program.
    Goswami C; Sheldon M; Bixby C; Keddache M; Bogdanowicz A; Wang Y; Schultz J; McDevitt J; LaPorta J; Kwon E; Buyske S; Garbolino D; Biloholowski G; Pastuszak A; Storella M; Bhalla A; Charlier-Rodriguez F; Hager R; Grimwood R; Nahas SA
    BMC Infect Dis; 2022 Apr; 22(1):404. PubMed ID: 35468749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development.
    Islam MA; Shahi S; Marzan AA; Amin MR; Hasan MN; Hoque MN; Ghosh A; Barua A; Khan A; Dhama K; Chakraborty C; Bhattacharya P; Wei DQ
    Front Pharmacol; 2023; 14():1090717. PubMed ID: 36825152
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid and qualitative identification of SARS-CoV-2 mutations associated with variants of concern using a multiplex RT-PCR assay coupled with melting analysis.
    Sberna G; Fabeni L; Berno G; Carletti F; Specchiarello E; Colavita F; Meschi S; Matusali G; Garbuglia AR; Bordi L; Lalle E
    Int J Infect Dis; 2022 Sep; 122():401-404. PubMed ID: 35760381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Description of a One-Year Succession of Variants of Interest and Concern of SARS-CoV-2 in Venezuela.
    Jaspe RC; Loureiro CL; Sulbaran Y; Moros ZC; D'Angelo P; Hidalgo M; Rodríguez L; Alarcón V; Aguilar M; Sánchez D; Ramírez J; Garzaro DJ; Zambrano JL; Liprandi F; Rangel HR; Pujol FH
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Most frequently harboured missense variants of hACE2 across different populations exhibit varying patterns of binding interaction with spike glycoproteins of emerging SARS-CoV-2 of different lineages.
    Tahsin A; Ahmed R; Bhattacharjee P; Adiba M; Al Saba A; Yasmin T; Chakraborty S; Hasan AKMM; Nabi AHMN
    Comput Biol Med; 2022 Sep; 148():105903. PubMed ID: 35932731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Silico Comparative Analysis of the Functional, Structural, and Evolutionary Properties of SARS-CoV-2 Variant Spike Proteins.
    Math RK; Mudennavar N; Javaregowda PK; Savanur A
    JMIR Bioinform Biotechnol; 2022; 3(1):e37391. PubMed ID: 35669291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Variants Identification; A Fast and Affordable Strategy Based on Partial S-Gene Targeted PCR Sequencing.
    Martínez-Murcia A; Garcia-Sirera A; Navarro A; Pérez L
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lebanese SARS-CoV-2 genomics: 24 months of the pandemic.
    Fayad N; Habib WA; El-Shesheny R; Kandeil A; Mourad Y; Mokhbat J; Kayali G; Goldstein J; Abdallah J
    Virus Res; 2022 Aug; 317():198824. PubMed ID: 35605880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of Major SARS-CoV-2 Variants of Concern in Clinical Samples via CRISPR-Cas12a-Mediated Mutation-Specific Assay.
    Liang Y; Zou L; Lin H; Li B; Zhao J; Wang H; Sun J; Chen J; Mo Y; Yang X; Deng X; Tang S
    ACS Synth Biol; 2022 May; 11(5):1811-1823. PubMed ID: 35481381
    [No Abstract]   [Full Text] [Related]  

  • 40. Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage.
    La Rosa G; Brandtner D; Bonanno Ferraro G; Veneri C; Mancini P; Iaconelli M; Lucentini L; Del Giudice C; Orlandi L; ; Suffredini E
    Sci Total Environ; 2023 May; 873():162339. PubMed ID: 36813191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.